{"id":"https://openalex.org/W2090476338","doi":"https://doi.org/10.1046/j.1365-2141.2003.04654.x","title":"Smoldering multiple myeloma: natural history and recognition of an evolving type","display_name":"Smoldering multiple myeloma: natural history and recognition of an evolving type","alternate_titles":[],"publication_year":2003,"publication_date":"2003-11-01","ids":{"openalex":"https://openalex.org/W2090476338","doi":"https://doi.org/10.1046/j.1365-2141.2003.04654.x","mag":"2090476338","pmid":"https://pubmed.ncbi.nlm.nih.gov/14616966"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2141.2003.04654.x","doi":"https://doi.org/10.1046/j.1365-2141.2003.04654.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2141.2003.04654.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2090476338"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015898454","display_name":"Laura Rosi\u00f1ol","orcid":"https://orcid.org/0000-0002-2534-9239","observed_orcids":["https://orcid.org/0000-0002-2534-9239"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Rosi\u00f1ol","raw_affiliation_strings":["Hematology Department, Institut Cl\u00ednic de Malalties Hemato-Oncol\u00f2giques, Hospital Cl\u00ednic, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Institut Cl\u00ednic de Malalties Hemato-Oncol\u00f2giques, Hospital Cl\u00ednic, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031837957","display_name":"Joan Blad\u00e9","orcid":"https://orcid.org/0000-0002-4563-3405","observed_orcids":["https://orcid.org/0000-0002-4563-3405"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. Blad\u00e9","raw_affiliation_strings":["Hematology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","Hematology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","institution_ids":[]},{"raw_affiliation_string":"Hematology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017225753","display_name":"Jordi Esteve","orcid":"https://orcid.org/0000-0002-8056-648X","observed_orcids":["https://orcid.org/0000-0002-8056-648X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Esteve","raw_affiliation_strings":["Hematology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","Hematology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","institution_ids":[]},{"raw_affiliation_string":"Hematology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063421244","display_name":"Marta Aymerich","orcid":"https://orcid.org/0000-0001-6286-7353","observed_orcids":["https://orcid.org/0000-0001-6286-7353"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Aymerich","raw_affiliation_strings":["Hematopathology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","Hematopathology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematopathology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","institution_ids":[]},{"raw_affiliation_string":"Hematopathology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061167008","display_name":"Mar\u00eda Rozman","orcid":"https://orcid.org/0000-0002-2641-1110","observed_orcids":["https://orcid.org/0000-0002-2641-1110"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Rozman","raw_affiliation_strings":["Hematopathology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","Hematopathology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematopathology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","institution_ids":[]},{"raw_affiliation_string":"Hematopathology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008706897","display_name":"Silvia Montoto","orcid":"https://orcid.org/0000-0002-3006-9725","observed_orcids":["https://orcid.org/0000-0002-3006-9725"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Montoto","raw_affiliation_strings":["Hematology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","Hematology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","institution_ids":[]},{"raw_affiliation_string":"Hematology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052695708","display_name":"Eva Gin\u00e9","orcid":"https://orcid.org/0000-0002-0532-1204","observed_orcids":["https://orcid.org/0000-0002-0532-1204"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. Gin\u00e9","raw_affiliation_strings":["Hematology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","Hematology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","institution_ids":[]},{"raw_affiliation_string":"Hematology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111874948","display_name":"Elisabet Nadal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. Nadal","raw_affiliation_strings":["Hematology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","Hematology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","institution_ids":[]},{"raw_affiliation_string":"Hematology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082392576","display_name":"Xavier Filella","orcid":"https://orcid.org/0000-0001-5201-4162","observed_orcids":["https://orcid.org/0000-0001-5201-4162"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"X. Filella","raw_affiliation_strings":["Biochemistry Department, Institut d'Investigacions Biome\u0300diques Agusti\u0301 Pi i Sunyer (IDIBAPS), Hospital Cli\u0301nic, University of Barcelona, Barcelona, Spain","Biochemistry Department, Institut d'Investigacions Biom\u00e8diques Agust\u00ed Pi i Sunyer (IDIBAPS), Hospital Cl\u00ednic, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biochemistry Department, Institut d'Investigacions Biome\u0300diques Agusti\u0301 Pi i Sunyer (IDIBAPS), Hospital Cli\u0301nic, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I71999127"]},{"raw_affiliation_string":"Biochemistry Department, Institut d'Investigacions Biom\u00e8diques Agust\u00ed Pi i Sunyer (IDIBAPS), Hospital Cl\u00ednic, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Queralt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Queralt","raw_affiliation_strings":["Hematopathology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","Hematopathology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematopathology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","institution_ids":[]},{"raw_affiliation_string":"Hematopathology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076083064","display_name":"Ana Carri\u00f3","orcid":"https://orcid.org/0000-0002-8394-2321","observed_orcids":["https://orcid.org/0000-0002-8394-2321"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Carri\u00f3","raw_affiliation_strings":["Hematopathology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","Hematopathology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematopathology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","institution_ids":[]},{"raw_affiliation_string":"Hematopathology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068240503","display_name":"Emili Montserrat","orcid":"https://orcid.org/0000-0002-2868-995X","observed_orcids":["https://orcid.org/0000-0002-2868-995X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. Montserrat","raw_affiliation_strings":["Hematology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","Hematology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Institut Cli\u0301nic de Malalties Hemato-Oncolo\u0300giques","institution_ids":[]},{"raw_affiliation_string":"Hematology Department, Institut Cl\u00ednic de Malalties Hemato\u2010Oncol\u00f2giques","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5031837957"],"corresponding_institution_ids":[],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":1.2893,"has_fulltext":false,"cited_by_count":155,"citation_normalized_percentile":{"value":0.78593015,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"123","issue":"4","first_page":"631","last_page":"636"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/smoldering-multiple-myeloma","display_name":"smoldering multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/monoclonal-gammopathy-of-undetermined-significance","display_name":"monoclonal gammopathy of undetermined significance","score":0.9129999876022339},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.7200000286102295},{"id":"https://openalex.org/keywords/iga-monoclonal-gammopathy","display_name":"IgA monoclonal gammopathy","score":0.7279999852180481},{"id":"https://openalex.org/keywords/serum-m-protein","display_name":"serum M-protein","score":0.8830000162124634},{"id":"https://openalex.org/keywords/bone-marrow-plasma-cells","display_name":"bone marrow plasma cells","score":0.8840000033378601},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7670000195503235},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.652999997138977},{"id":"https://openalex.org/keywords/osteolytic-lesions","display_name":"osteolytic lesions","score":0.878000020980835},{"id":"https://openalex.org/keywords/chemotherapy-response","display_name":"chemotherapy response","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.8837912082672119},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7916029691696167},{"id":"https://openalex.org/C2777250017","wikidata":"https://www.wikidata.org/wiki/Q458138","display_name":"Monoclonal gammopathy of undetermined significance","level":5,"score":0.685636043548584},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.6144497990608215},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.5289615988731384},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5213083624839783},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4936593472957611},{"id":"https://openalex.org/C188758523","wikidata":"https://www.wikidata.org/wiki/Q6947334","display_name":"Myeloma protein","level":3,"score":0.4546854496002197},{"id":"https://openalex.org/C2779674975","wikidata":"https://www.wikidata.org/wiki/Q1474877","display_name":"Hypercalcaemia","level":3,"score":0.4374043345451355},{"id":"https://openalex.org/C163276114","wikidata":"https://www.wikidata.org/wiki/Q484591","display_name":"Natural history","level":2,"score":0.4112923741340637},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.25294211506843567},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2275080680847168},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18250316381454468},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.11286565661430359},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001856","descriptor_name":"Bone Marrow Examination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009194","descriptor_name":"Myeloma Proteins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D010950","descriptor_name":"Plasma Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2141.2003.04654.x","doi":"https://doi.org/10.1046/j.1365-2141.2003.04654.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2141.2003.04654.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:14616966","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14616966","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W25292609","https://openalex.org/W1545206303","https://openalex.org/W1967469159","https://openalex.org/W1971353106","https://openalex.org/W1978377409","https://openalex.org/W1979300931","https://openalex.org/W2000655497","https://openalex.org/W2002927100","https://openalex.org/W2019336481","https://openalex.org/W2030894550","https://openalex.org/W2053784212","https://openalex.org/W2606199847","https://openalex.org/W3041047318","https://openalex.org/W3143387670","https://openalex.org/W3148655431","https://openalex.org/W4241442958","https://openalex.org/W4298434897"],"related_works":["https://openalex.org/W4248138322","https://openalex.org/W2789928137","https://openalex.org/W2900114513","https://openalex.org/W2980193762","https://openalex.org/W2803924660","https://openalex.org/W2606311392","https://openalex.org/W2623846172","https://openalex.org/W1964361833","https://openalex.org/W34072302","https://openalex.org/W1988876144"],"abstract_inverted_index":{"Patients":[0],"with":[1,31,94,126],"smoldering":[2],"multiple":[3,11],"myeloma":[4,12],"(SMM)":[5],"meet":[6],"the":[7,115,122,133],"diagnostic":[8],"criteria":[9],"of":[10,39,52,75,84,148,151,168],"(MM)":[13],"but":[14],"are":[15],"asymptomatic.":[16],"Between":[17],"January":[18],"1978":[19],"and":[20,37,47,79,87,121,183,188],"July":[21],"2001,":[22],"53":[23],"patients":[24,105,169],"(median":[25],"age":[26],"63":[27],"years)":[28],"were":[29,44,54],"diagnosed":[30],"SMM.":[32],"The":[33,109,146,178],"median":[34,110,179],"serum":[35,68],"M-protein":[36,96],"proportion":[38,83],"bone":[40,154],"marrow":[41],"plasma":[42],"cells":[43],"36":[45],"g/l":[46],"27%":[48],"respectively.":[49,191],"Two":[50],"subsets":[51],"SMM":[53,58,90],"identified:":[55],"(i)":[56],"evolving":[57,134],"(n":[59,91],"=":[60,92,144],"22),":[61],"characterized":[62],"by":[63],"a":[64,70,80,127],"progressive":[65],"increase":[66],"in":[67,114],"M-protein,":[69],"previously":[71],"recognized":[72],"monoclonal":[73],"gammopathy":[74],"undetermined":[76],"significance":[77],"(MGUS)":[78],"significant":[81],"higher":[82],"IgA":[85],"type":[86,137],"(ii)":[88],"non-evolving":[89,136],"26)":[93],"stable":[95],"that":[97,170],"abruptly":[98],"increases":[99],"when":[100],"symptomatic":[101,107],"MM":[102],"develops.":[103],"Thirty-four":[104],"developed":[106],"MM.":[108],"time":[111,129],"to":[112,130],"progression":[113,131,149,185],"overall":[116],"series":[117],"was":[118,132,186],"3.2":[119],"years":[120,141,190],"only":[123],"feature":[124],"associated":[125],"shorter":[128],"versus":[135],"(1.3":[138],"vs.":[139],"3.9":[140],"respectively,":[142],"P":[143],"0.007).":[145],"pattern":[147],"consisted":[150],"anaemia,":[152],"lytic":[153],"lesions":[155],"or":[156,162,175],"both,":[157],"without":[158],"renal":[159],"failure,":[160],"hypercalcaemia":[161],"extramedullary":[163],"plasmacytomas.":[164],"Fifty-seven":[165],"per":[166],"cent":[167],"required":[171],"chemotherapy":[172],"showed":[173],"no":[174],"minimal":[176],"response.":[177],"survival":[180],"from":[181,184],"diagnosis":[182],"8.2":[187],"3.5":[189]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2090476338","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
